Molecular mimicry of the NF-κB DNA target site by a selected RNA aptamer

Current Opinion in Structural Biology

Volumn 14, Issue 1, 2004, Pages 21-27

  Ghosh, Gourisankar ^a   Huang, De Bin ^a   Huxford, Tom ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Base pairs; bp; C terminal domain; CTD; Ig; Immunoglobulin; N terminal domain; nt; NTD; Nucleotide; Rel homology region; RHR

Indexed keywords

APTAMER; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; RNA; TRANSCRIPTION FACTOR;

BINDING AFFINITY; CRYSTAL STRUCTURE; DNA BINDING; GENE TARGETING; HUMAN; MOLECULAR MIMICRY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; RNA BINDING; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; X RAY ANALYSIS;

EID: 1342345186     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2004.01.004     Document Type: Review

References (35)

1. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
2. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10:1994;405-455.
3. Baldwin A.S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
4. Ghosh S., May M.J., Kopp E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
5. Chen F.E., Ghosh G. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene. 18:1999;6845-6852.
6. Lin A., Karin M. NF-κB in cancer: a marked target. Semin Cancer Biol. 13:2003;107-114.
7. Lebruska L.L., Maher L.J. III Selection and characterization of an RNA decoy for transcription factor NF-κB. Biochemistry. 38:1999;3168-3174.
8. Cassiday L.A., Maher L.J. III Yeast genetic selections to optimize RNA decoys for transcription factor NF-κB. Proc. Natl. Acad. Sci. USA. 100:2003;3930-3935 Genetic selection in yeast was used to optimize an in vitro selected RNA aptamer for active NF-κB binding. RNA aptamers derived using these methods exhibit enhanced NF-κB inhibitory activity in yeast. This study illustrates the power of combining both in vitro chemical and in vivo genetic selection techniques to optimize RNA aptamer biological activities.
9. Cassiday L.A., Maher L.J. III In vivo recognition of an RNA aptamer by its transcription factor target. Biochemistry. 40:2001;2433-2438.
10. 2 complexed to a high-affinity RNA aptamer. Proc. Natl. Acad. Sci. USA. 100:2003;9268-9273 This paper reports the X-ray crystal structure of the NF-κB p50 RHR-RNA aptamer complex at 2.45 Å resolution. The structure is presented in detail, with a focus on the nucleic acid stereochemistry and protein-RNA interface.
11. Müller C.W., Rey F.A., Sodeoka M., Verdine G.L., Harrison S.C. Structure of the NF-κB p50 homodimer bound to DNA. Nature. 373:1995;311-317.
12. Ghosh G., van Duyne G., Ghosh S., Sigler P.B. Structure of NF-κB p50 homodimer bound to a κB site. Nature. 373:1995;303-310.
13. Huxford T, Ghosh G: The structural biology of NF-κB. In Nuclear Factor κB: Regulation and Role in Disease. Edited by Beyaert R. Netherlands: Kluwer; 2003:179-200.
14. Chen F.E., Huang D.B., Chen Y.Q., Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature. 391:1998;410-413.
15. Chen-Park F.E., Huang D.B., Noro B., Thanos D., Ghosh G. The κB DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J. Biol. Chem. 277:2002;24701-24708.
16. Cramer P., Larson C.J., Verdine G.L., Müller C.W. Structure of the human NF-κB p52 homodimer-DNA complex at 2.1. Å resolution EMBO J. 16:1997;7078-7090.
17. Chen Y.Q., Ghosh S., Ghosh G. A novel DNA recognition mode by the NF-κB p65 homodimer. Nat. Struct. Biol. 5:1998;67-73.
18. Chen Y.Q., Sengchanthalangsy L.L., Hackett A., Ghosh G. NF-κB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets. Structure. 8:2000;419-428.
19. Huang D.B., Chen Y.Q., Ruetsche M., Phelps C.B., Ghosh G. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure. 9:2001;669-678.
20. Hermann T., Patel D.J. Stitching together RNA tertiary architectures. J. Mol. Biol. 294:1999;829-849.
21. Hermann T., Patel D.J. Adaptive recognition by nucleic acid aptamers. Science. 287:2000;820-825.
22. Hermann T., Patel D.J. RNA bulges as architectural and recognition motifs. Structure. 8:2000;R47-R54.
23. Liu J., Fan Q.R., Sodeoka M., Lane W.S., Verdine G.L. DNA binding by an amino acid residue in the C-terminal half of the Rel homology region. Chem. Biol. 1:1994;47-55.
24. Cassiday L.A., Lebruska L.L., Benson L.M., Naylor S., Owen W.G., Maher L.J. III Binding stoichiometry of an RNA aptamer and its transcription factor target. Anal. Biochem. 306:2002;290-297 The techniques of analytical ultracentrifugation and microelectrospray mass spectrometry were employed to determine the binding stoichiometry of an RNA aptamer and NF-κB p50 homodimer. Both methods predict a binding stoichiometry of one RNA aptamer per NF-κB dimer. Although this contradicts the stoichiometry observed in the complex crystal structure, it appears that each RNA aptamer binds independently to NF-κB p50 subunits and that the binding of two RNAs to one p50 homodimer facilitates crystallization.
25. Phelps C.B., Sengchanthalangsy L.L., Malek S., Ghosh G. Mechanism of κB DNA binding by Rel/NF-κB dimers. J. Biol Chem. 275:2000;24392-24399.
26. Sitcheran R., Cogdwell P.C., Baldwin A.S.J. NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 17:2003;2368-2373.
27. Peyman J.A. Mammalian expression cloning of two human trophoblast suppressors of major histocompatibility complex genes. Am. J. Reprod. Immunol. 45:2001;382-392.
28. Becker S., Groner B., Müller C.W. Three-dimensional structure of the Stat3β homodimer bound to DNA. Nature. 394:1998;145-151.
29. Chen X., Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell J.E. Jr., Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell. 93:1998;827-839.
30. Jin L., Sliz P., Chen L., Macian F., Rao A., Hogan P.G., Harrison S.C. An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site. Nat. Struct. Biol. 10:2003;807-811.
31. Wolfe S.A., Zhou P., Dotsch V., Chen L., You A., Ho S.N., Crabtree G.R., Wagner G., Verdine G.L. Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc. Nature. 385:1997;172-176.
32. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 265:1994;346-355.
33. Eddy S.R. Non-coding RNA genes and the modern RNA world. Nat. Rev. Genet. 2:2001;919-929.
34. Mattick J.S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2:2001;986-991.
35. Cassiday L.A., Maher L.J. III Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res. 30:2002;4118-4126 An excellent review of evidence supporting the binding of some transcription factors to both DNA and RNA targets.